Articles with keyword inhibitor

• Immune checkpoint inhibitors in the treatment of cervical cancer: literature review

  O.A. Pardabekova

  cervical cancer, immunotherapy, immune checkpoint inhibitors, pd-1,

• Prospects for the use of small interfering RNAs as inhibitors of immune checkpoints for immunotherapy in oncology

  A.A. Bogdanov, V.V. Vysochinskaya, A.A. Kornev, A.K. Emelyanov, An.A. Bogdanov, V.M. Moiseyenko

  immunotherapy, adaptive cell therapy, RNA interference, targeted therapy, immune checkpoint inhibitors.

• Neoadjuvant anti PD-1 / PD-L1 immune checkpoint inhibitors in locall y advanced gastric cancer with microsatellite insta bility

  A.Y. Navmatulya, V.A. Chubenko, S.A. Savchuk, F.R. Almukhametova, P.Y. Tsuprun, A.I. Kuznetsov, G.S. Inusilaev, V.A. Heinstein, K.V. Shelekhova, Е.М. Zykov, B.I. Miroshnikov, V.M. Moiseenko

  Gastric cancer, immune checkpoint inhibitors, MSI, microsatellite instability, PD-1, PD-L1, objective response, pathologic response.

• Systemic treatment of hepatocellular carcinoma: practical issues and perspectives

  V.V. Breder, K.K. Laktionov

  hepatocellular carcinoma, multi-kinase inhibitors, checkpoint inhibitors.

• 2018 NOBEL PRIZE IN PHYSIOLOGY OR MEDICINE

  F.V. Moiseenko, V.M. Moiseyenko

  cancer, treatment, immunotherapy, checkpoint inhibitors.

• MOLECULAR TARGETS IN LUNG CANCER: CURRENT STATUS

  E.N. Imyanitov

  lung cancer, mutation, smoking, tumor, inhibitor

• Is it possible to get survival benefit in advanced malignant tumors? (datA from trials, critical aspects)

  A.I. Semenova

  urothelial carcinoma, immune checkpoint inhibitors, enfortumab vetodin

• New and promising immune oncology drugs combinations

  N.М. Volkov

  malignant tumors, cancer immunotherapy, immune check-point inhibitors, combinations.

• Combinations of immunotherapy and other drugs

  V.A. Chubenko

  Target therapy, chemotherapy, check-point inhibitors, overall survival.

• FUTURE OF SYSTEMIC THERAPY IN ONCOUROLOGY: TARGETED AND IMMUNOTHERAPY

  F.V. Moiseenko

  immunotherapy, targeted therapy, checkpoint inhibitors, urothelial cancer, renal cell cancer.

• 2015 main events in drug therapy

  F.V. Moiseenko

  immunotherapy, program cell death protein inhibitors, targeted therapy, cancer drug therapy

• 20 YEARS OF TARGETING THERAPY OF SOLID TUMORS. SUCCESSES AND FAILURES

  A.A. Tryakin, M.Yu. Fedyanin, I.A. Pokataev

  targeted therapy, precision medicine, tyrosine kinase inhibitor, biomarker, oncology; review.

• History of immunotherapy of malignant tumors

  M.M. Kramchaninov, V.M. Moiseenko

  cancer, solid tumors, antitumour drugs, immunotherapy, monoclonal antibodies, checkpoint inhibitors

• CANCER IMMUNOTHERAPY

  N.M. Volkov

  cancer immunotherapy, immune check-point inhibitors, chimeric antigen receptor, clinical trials.

• A history of cancer immunotherapy

  V.M. Moiseyenko, N.M. Volkov

  anticancer immunity, cancer immunotherapy, history, vaccines, cytokines, adoptive therapy, antibody, immune check-point inhibitor

• Immunotherapy: Neoadjuvant and/or adjuvant? Literature review

  N.A. Falaleeva, E.A. Bykova, L.Yu. Grivtsova, A.S. Belokhvostova, A.А. Danilenko, I.S. Pimonova, P.V. Shegai, S.A. Ivanov, A.D. Kaprin

  Neoadjuvant immunotherapy, immune checkpoint inhibitors, breast cancer, colorectal cancer, non-small cell lung cancer, nonspecific immunotropic therapy.